
Solvay SA (SOLB) | Financial Analysis & Statements
Solvay SA | Large-cap | Basic Materials
Solvay SA | Large-cap | Basic Materials
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
5.1B
Gross Profit
1.1B
22.34%
Operating Income
651.0M
12.69%
Net Income
233.0M
4.54%
EPS (Diluted)
€2.10
Balance Sheet Metrics
Total Assets
6.7B
Total Liabilities
5.3B
Shareholders Equity
1.4B
Debt to Equity
3.77
Cash Flow Metrics
Operating Cash Flow
280.0M
Free Cash Flow
330.0M
Revenue & Profitability Trend
Solvay SA Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 5.1B | 6.0B | 8.0B | 11.4B | 9.7B |
Cost of Goods Sold | 4.0B | 4.6B | 6.6B | 8.5B | 7.2B |
Gross Profit | 1.1B | 1.4B | 1.4B | 2.9B | 2.5B |
Operating Expenses | 491.0M | 573.0M | 440.0M | 1.5B | 1.5B |
Operating Income | 651.0M | 803.0M | 805.0M | 1.2B | 844.0M |
Pre-tax Income | 320.0M | 180.0M | 1.1B | 1.1B | -844.0M |
Income Tax | 87.0M | 208.0M | 228.0M | 110.0M | 248.0M |
Net Income | 233.0M | 2.1B | 1.9B | 989.0M | -929.0M |
EPS (Diluted) | €2.10 | €19.85 | €18.30 | €9.13 | -€9.32 |
Income Statement Trend
Solvay SA Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 2.5B | 2.7B | 7.0B | 6.8B | 4.5B |
Non-Current Assets | 4.2B | 4.3B | 13.7B | 13.2B | 12.3B |
Total Assets | 6.7B | 7.0B | 20.7B | 20.0B | 16.8B |
Liabilities | |||||
Current Liabilities | 1.9B | 2.2B | 4.9B | 5.5B | 2.8B |
Non-Current Liabilities | 3.4B | 3.5B | 5.1B | 5.7B | 6.7B |
Total Liabilities | 5.3B | 5.7B | 10.0B | 11.2B | 9.5B |
Equity | |||||
Total Shareholders Equity | 1.4B | 1.3B | 10.7B | 8.9B | 7.3B |
Balance Sheet Composition
Solvay SA Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 233.0M | 2.1B | 1.9B | 989.0M | -929.0M |
Operating Cash Flow | 280.0M | 1.2B | 1.4B | 104.0M | -795.0M |
Investing Activities | |||||
Capital Expenditures | -261.0M | -960.0M | -794.0M | -531.0M | -446.0M |
Investing Cash Flow | -286.0M | -1.7B | -730.0M | -426.0M | 762.0M |
Financing Activities | |||||
Dividends Paid | -260.0M | -424.0M | -417.0M | -431.0M | -419.0M |
Financing Cash Flow | -228.0M | -344.0M | -1.0B | -952.0M | -1.5B |
Free Cash Flow | 330.0M | 847.0M | 1.1B | 863.0M | 693.0M |
Cash Flow Trend
Solvay SA Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.83
Forward P/E
7.23
Price to Book
2.26
Price to Sales
0.61
PEG Ratio
7.23
Profitability Ratios
Profit Margin
3.88%
Operating Margin
11.83%
Return on Equity
14.16%
Return on Assets
5.18%
Financial Health
Current Ratio
1.38
Debt to Equity
155.68
Beta
0.67
Per Share Data
EPS (TTM)
€1.86
Book Value per Share
€13.02
Revenue per Share
€48.41
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
solb | 3.1B | 15.83 | 2.26 | 14.16% | 3.88% | 155.68 |
Syneos Health | 6.9B | 377.86 | 1.03 | -1.38% | -1.59% | 28.51 |
Basilix Cert | 3.7M | - | - | 695.33% | 0.00% | 25.22 |
Anheuser-Busch InBev | 120.4B | 21.06 | 1.57 | 6.60% | 11.75% | 81.53 |
Azelis Group NV | 3.2B | 17.86 | 1.12 | 6.77% | 4.29% | 63.15 |
Titan Cement | 2.9B | 9.97 | 1.41 | 15.09% | 10.55% | 33.45 |
Financial data is updated regularly. All figures are in the company's reporting currency.